NEW YORK, Dec. 06, 2016 -- Dr. Michael Irwin, Director and Cousins Distinguished Professor of Psychiatry at UCLA Medical Center, has been selected to join the Physician Board at the American Health Council. He will be sharing his knowledge and expertise in the areas of Neuropsychiatry, Psychiatry, and Psychoneuroimmunology.
|
|||||
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/d330d72a-0ea3-4752-844f-fd3d59a8468d
Dr. Irwin has been active in the healthcare industry for the past 35 years. He obtained his MD from the University of California, San Diego, in 1981, and completed his Residency at the UCLA School of Medicine in 1985. Dr. Irwin’s strong interest in behavioral health led him to his current profession. His day-to-day responsibilities include research regarding how inflammation can affect depression and the regulation of the immune system and oversight of a staff of 50 and a junior staff of 5 direct reports. He is also responsible for over $5 million worth of NIH funding.
Dr. Irwin attributes his success to luck and opportunity, hard work, being intuitive, attending and working for an excellent school, and the amazing support of his family. Among his many accomplishments, he is most proud of those that he has mentored and trained and their great success. He has been published in over 340 research articles, 2 books, and several yearly lectures. His long-term goals include establish primary care models for the underserved.
Dr. Irwin’s many awards and honors include the Early Career Award, American Psychosomatic Society (1991); President, Psychoneuroimmunology Research Society (2001); Member, National Advisory Council, Center for Complementary and Alternative Medicine (2001-2004); President, Academy of Behavioral Medicine Research (2003); Outstanding Faculty Research Mentor Award, UCLA School of Medicine (2005); Norman Cousins Research Award, Psychoneuroimmunology Research Society (2007); Chair, Blue Ribbon Intramural Research Strategic Planning Panel, NCCAM (2008); Distinguished Fellow, American Psychiatric Association (2008); Secretary Treasurer, American Psychosomatic Society (2008-2010); Lauda Wellness Award (2009); President-Elect/President, American Psychosomatic Society (2010-2011); Best Research Prize, European Society of Integrative Medicine (2014); and Chairperson, IH Centers for Scientific Review, Mechanisms of Emotion, Stress and Health Study Section (2014-2016).
Dr. Irwin has received funding awards from the National Institute of Aging, National Cancer Institute, National Heart Lung and Blood Disorders Institute, National Institute of Alcoholism and Alcohol Abuse, National Institute of Arthritis and Musculoskeletal Disorders, National Institute of Drug Abuse, National Center for Complementary and Alternative Medicine (NCCAM), and the National Institute of Mental Health.
Charitable organizations he is involved with include UCLA, Cornell University, and University of Pennsylvania.
Dr. Irwin is proud to have had his research on Meditation published in the Los Angeles Times.
For more information, please contact: Elizabeth Moore American Health Council Hauppauge, NY United States Phone: 1-212-390-0214 Email: [email protected]


MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding?
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
First Western Ship Transits Strait of Hormuz Since Iran War Began
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
Luxury Car Sales in the Middle East Take a Hit Amid Iran War 



